Related Experiment Video
Updated: Jan 23, 2026

08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
4.8K
Nitric oxide: a drug target for glaucoma revisited
Gerhard Garhöfer1, Leopold Schmetterer2
1Department of Clinical Pharmacology, Medical University of Vienna, Austria.
Drug Discovery Today
|June 8, 2019
Summary
Nitric oxide (NO)-donating drugs lower intraocular pressure (IOP) by increasing fluid outflow through the trabecular meshwork. This review explores the molecular mechanisms of these novel antiglaucoma medications.
Area of Science:
- Ophthalmology
- Pharmacology
- Molecular Biology
Background:
- Glaucoma treatment relies solely on reducing intraocular pressure (IOP).
- Nitric oxide (NO) plays a key role in regulating IOP by influencing trabecular meshwork outflow.
- Developing drugs that lower IOP is crucial for glaucoma management.
Purpose of the Study:
- To review the molecular mechanisms of novel nitric oxide (NO)-donating drugs for glaucoma.
- To explore how these drugs combine established hypotensive effects with NO-mediated outflow enhancement.
Main Methods:
- Review of existing scientific literature on NO's role in IOP regulation.
- Analysis of the molecular mechanisms of NO-donating antiglaucoma drugs.
- Examination of how these drugs affect trabecular meshwork outflow.
Main Results:
- Nitric oxide (NO) directly impacts the trabecular meshwork, facilitating aqueous humor outflow.
- NO-donating drugs leverage this mechanism to lower intraocular pressure (IOP).
- These novel drugs offer a dual action: combining known IOP-lowering effects with NO-induced outflow enhancement.
Conclusions:
- Nitric oxide (NO)-donating drugs represent a promising new class of antiglaucoma therapeutics.
- Understanding the molecular mechanisms is key to optimizing the efficacy of these drugs.
- These agents enhance trabecular meshwork outflow, offering a novel approach to glaucoma management.
Related Concept Videos
Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K
Targets for Drug Action: Overview
10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Oxidation Numbers
42.3K
In redox reactions, the transfer of electrons occurs between reacting species. Electron transfer is described by a hypothetical number called the oxidation number (or oxidation state). It represents the effective charge of an atom or element, which is assigned using a set of rules.
42.3K
Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Pyruvate Oxidation
168.5K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.5K

